BCBSM and ASC customers recently received a notice (PDF) of a class action drug settlement from the U.S. District Court for the District of Delaware.
Here’s the background:
“The lawsuit claims that the Defendants violated antitrust and consumer protection laws by keeping lower cost generic versions of Toprol XL® off the market. The Defendants deny this. No one is claiming that Toprol XL®or its generic are unsafe or ineffective.”Go to main navigation